Dr. Athanasia Sandali is a physician and an aspiring ophthalmologist. She earned her medical degree and an MSc in ocular surgery from Aristotle University of Thessaloniki, graduating with distinction. While working towards obtaining her specialty in ophthalmology, she has been actively engaged in various research projects focused on pediatric ophthalmology, including AI-driven diagnostics, gene therapy, and strabismus. Her works have been published in distinguished journals such as Acta Ophthalmologica and the European Journal of Ophthalmology and presented at prestigious congresses such as the Association for Research in Vision and Ophthalmology (ARVO) meeting and the European Association for Vision and Eye Research (EVER) Congress.
The authors of a review of 16 gene therapy trials for inherited retinal diseases explain why the pediatric evidence base remains thin and argue that individual-level, age-stratified reporting is the change most needed before CRISPR-based editing reaches children.
